National Funds
Project COV20-00214 COVARNA
Preclinical development of innovative mRNA / MVA vaccines against SARS- CoV2 "(COVARNA) - COVID-19 ISCIII
date_range
Duration: from 30 April 2020 to 30 October 2021
(18 months)
Finished
With a Public character. It has been granted under a regime of Competitive.
Call:
COVID-19 ISCIII
